drugset / Trial / NCT05411978

Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients

NCT05411978

Phase 4 Unknown 900 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

This is a multi-center, prospective, double-blind randomized controlled trial on a sample of patients with migraine. Subjects will only be enrolled when a physician or research assistant who is familiar with the study protocol is available to enroll patients. Written, informed consent will be obtained from each patient. Consent will include a discussion of the risks and benefits.

Timeline

Start
2022-05-09
Primary completion
2024-06-20
Completion
2024-06-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Idebenone Small molecule 30 mg Oral
Comparator Idebenone Small molecule 90 mg Oral

Indications